Osteoporosis and atherosclerosis are both consequences of aging and both are associated with increased levels of oxidized lipids and inflammatory cytokines. ApoE null (ApoE-KO) mice fed a high fat diet (HFD) develop atherosclerosis, due in part to activation of vascular inflammation by oxidized low density lipoprotein (oxLDL). Since bone loss also occurs in these mice, we used them to investigate the impact of oxidized lipids on bone homeostasis, and to search for underlying pathogenic pathways. Four-month-old female ApoE-KO mice fed a HFD for three months exhibited increased levels of oxidized lipids in bone, as well as decreased femoral and vertebral trabecular and cortical bone mass, as compared to ApoE-KO mice on normal diet. Despite HFD-induced increase in expression of Alox15, a lipoxygenase that oxidizes LDL and promotes atherogenesis, global deletion of this gene failed to ameliorate the skeletal impact of HFD. Osteoblast number and function were dramatically reduced in trabecular and cortical bone of HFD-fed mice, whereas osteoclast number was modestly reduced only in trabecular bone, indicating that an imbalance in favor of osteoclasts was responsible for HFD-induced bone loss. These changes were associated with decreased osteoblast progenitors and increased monocyte/macrophages in the bone marrow, as well as increased expression of IL-1ß, IL-6 and TNF. The HFD also attenuated Wnt signaling as evidenced by reduced expression of Wnt target genes, and it decreased expression of pro-osteoblastogenic Wnt ligands. These results suggest that oxidized lipids decrease bone mass by increasing anti-osteoblastogenic inflammatory cytokines, and decreasing pro-osteoblastogenic Wnt ligands.
- bone remodeling
- Copyright © 2016, American Journal of Physiology - Endocrinology and Metabolism